GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Clever Culture Systems CC5.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.02

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Clever Culture Systems — daily ASX:CC5

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Clever Culture Systems on TradingView ↗
Market value
A$36.1m
Last close × shares

About Clever Culture Systems

Its shares trade on ASX under the ticker CC5.AX. It has been listed since 31 July 2006. In the fiscal year to 30 June 2026, it reported revenue of A$4.6m and a net loss of A$2.2m. At that date it held total assets of A$13.5m and shareholders' equity of A$7.5m.

LBT Innovations Ltd. is an Australian developer of clinical and diagnostic technology, which has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefits for busy clinical laboratories. The company is headquartered in Adelaide, South Australia. The company went IPO on 2006-07-31. Its principal activities includes researching, developing, and commercializing technologies for the healthcare and laboratory supply markets. Its capabilities include artificial intelligence (AI), image analysis and software engineering solutions that improve medical diagnostic workflows. Its Automated Plate Assessment System (APAS) is a platform technology that automates culture-plate screening and interpretation. Its products include APAS Independence and APAS Analysis Modules. The APAS Independence combines AI, software and imaging analysis to create a platform technology for intelligent image interpretation. The APAS Analysis Modules are the intelligent image analysis software that works together with the APAS Independence to enable the screening of microbiology culture plates. Its pipeline includes APAS- antimicrobial resistance (AMR) Analysis Module, Automated Gram Stain Assessment, Biofilm, MicroStreak and WoundVue.

Figures and description from our data supplier, not checked against the company's own report.

More about Clever Culture Systems →

Latest on Clever Culture Systems

Our reporting

We have not reported on Clever Culture Systems yet.

Next results

25 Feb 2027

Due on 25 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Clever Culture Systems's ticker?

Clever Culture Systems trades as CC5.AX on ASX, under ISIN AU0000367153.

What was Clever Culture Systems's last closing price?

0.02 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Clever Culture Systems next report results?

Results are expected on 25 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.